Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 3, 2011, Pages 967-973

  Li, Ming Han ^a   Luo, Yueh Hsia ^a   Lin, Chiou Feng ^a   Chang, Yu Tzu ^b   Lu, Shiou Ling ^a   Kuo, Chih Feng ^c   Hong, Jau Shyong ^d   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; DEXTROMETHORPHAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL LOAD; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; GROUP A STREPTOCOCCAL INFECTION; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; CELL SURVIVAL; DEXTROMETHORPHAN; MICE; MICE, INBRED BALB C; SEPSIS; STREPTOCOCCAL INFECTIONS;

EID: 79952321922     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00950-10     Document Type: Article

References (44)

1. Aikawa, C., et al. 2010. Reactive oxygen species induced by Streptococcus pyogenes invasion trigger apoptotic cell death in infected epithelial cells. Cell. Microbiol. 12:814-830.
2. Bisno, A. L., M. O. Brito, and C. M. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3:191-200.
3. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694.
4. Choi, D. W. 1987. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res. 403:333-336. (Pubitemid 17019714)
5. Cleary, P. P. 2006. Streptococcus moves inward. Nat. Med. 12:384-386.
6. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
7. Currie, B. J. 2006. Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress. Curr. Opin. Infect. Dis. 19:132-138.
8. Gloire, G., S. Legrand-Poels, and J. Piette. 2006. NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72:1493-1505.
9. Haberecht, M. F., C. K. Mitchell, G. J. Lo, and D. A. Redburn. 1997. N-Methyl-D-aspartate-mediated glutamate toxicity in the developing rabbit retina. J. Neurosci. Res. 47:416-426.
10. Kennedy, A. D., and F. R. DeLeo. 2009. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43:25-61.
11. Kobayashi, S. D., et al. 2003. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. U. S. A. 100:10948-10953.
12. Kuo, C. F., et al. 2004. Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection. Microb. Pathog. 36:273-285.
13. Kuo, C. F., et al. 1998. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect. Immun. 66:3931-3935.
14. Kurupati, P., et al. 2010. Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol. Microbiol. 76:1387-1397.
15. Li, G., et al. 2005. Protective effect of dextromethorphan against endotoxic shock in mice. Biochem. Pharmacol. 69:233-240.
16. Liu, P. Y., et al. 2008. Treatment with dextromethorphan improves endothelial function, inflammation and oxidative stress in male heavy smokers. J. Thromb. Haemost. 6:1685-1692.
17. Liu, S. L., et al. 2009. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovasc. Res. 82:161-169.
18. Liu, Y., et al. 2003. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J. Pharmacol. Exp. Ther. 305:212-218.
19. Medina, E., D. Anders, and G. S. Chhatwal. 2002. Induction of NF-κB nuclear translocation in human respiratory epithelial cells by group A streptococci. Microb. Pathog. 33:307-313.
20. Medina, E., O. Goldmann, A. W. Toppel, and G. S. Chhatwal. 2003. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. J. Infect. Dis. 187:597-603.
21. Musser, J. M., and F. R. DeLeo. 2005. Toward a genome-wide systems biology analysis of host-pathogen interaction in group A streptococcus. Am. J. Pathol. 167:1461-1472.
22. Nakagawa, I., M. Nakata, S. Kawabata, and S. Hamada. 2001. Cytochrome c-mediated caspase-9 activation triggers apoptosis in Streptococcus pyogenes-infected epithelial cells. Cell. Microbiol. 3:395-405.
23. Nizet, V. 2007. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120:13-22.
24. Norrby-Teglund, A., et al. 2000. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 30:3247-3255.
25. Norrby-Teglund, A., K. Pauksens, M. Norgren, and S. E. Holm. 1995. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand. J. Infect. Dis. 27:125-130.
26. Norrby-Teglund, A., et al. 2001. Evidence for superantigen involvement in severe group A streptococcal tissue infection. J. Infect. Dis. 186:853-860.
27. O'Connell, D. 2006. Bacterial pathogenesis: triggering GAS invasive disease. Nat. Rev. Microbiol. 4:644-645.
28. Olsen, R. J., S. A. Shelburne, and J. M. Musser. 2009. Molecular mechanisms underlying group A streptococcal pathogenesis. Cell. Microbiol. 11:1-12.
29. Pahlman, L. I., et al. 2008. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell. Microbiol. 10:404-414.
30. Proft, T., and J. D. Fraser. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133:299-306.
31. Quinn, M. T., M. C. Ammons, and F. R. DeLeo. 2006. The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin. Sci. (Lond.) 111:1-20.
32. Rosen, H., and S. J. Klebanoff. 1979. Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte. J. Exp. Med. 149:27-39.
33. Siu, A., and R. Drachtman. 2007. Dextromethorphan: a review of N-methyl-D-aspartate receptor antagonist in the management of pain. CNS Drug Rev. 13:96-106. (Pubitemid 46697843)
34. Smeesters, P. R., D. J. McMillan, and K. S. Sriprakash. 2010. The streptococcal M protein: a highly versatile molecule. Trends Microbiol. 18:275-282.
35. Staali, L., S. Bauer, M. Morgelin, L. Bjorck, and H. Tapper. 2006. Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell. Microbiol. 8:690-703.
36. Stevens, D. L. 1999. The flesh-eating bacterium: what's next? J. Infect. Dis. 179:S366-S374.
37. Stevens, D. L. 2000. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu. Rev. Med. 51:271-288.
38. Tart, A. H., M. J. Walker, and J. M. Musser. 2007. New understanding of the group A streptococcus pathogenesis cycle. Trends Microbiol. 15:318-325.
39. Tsai, P. J., Y. S. Lin, C. F. Kuo, H. Y. Lei, and J. J. Wu. 1999. Group A streptococcus induces apoptosis in human epithelial cells. Infect. Immun. 67:4334-4339.
40. Tsai, P. J., et al. 2006. Streptococcus pyogenes induces epithelial inflammatory responses through NF-κB/MAPK signaling pathways. Microbes Infect. 8:1440-1449.
41. Tsao, N., et al. 2001. Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob. Agents Chemother. 45:1788-1793.
42. Voyich, J. M., J. M. Musser, and F. R. DeLeo. 2004. Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect. 6:1117-1123.
43. Zagursky, R. J., and A. S. Anderson. 2008. Application of genomics in bacterial vaccine discovery: a decade in review. Curr. Opin. Pharmacol. 8:632-638.
44. Zhang, W., et al. 2004. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 18:589-591.